Strados Labs specializes in innovative respiratory health monitoring solutions, prominently featuring their FDA-cleared RESP® Biosensor. This wearable device allows for continuous and real-time monitoring of lung sounds, including coughs and wheezes, making it a revolutionary tool in both clinical and home settings. Patients can adhere the device to their chest, with data captured being sent to a mobile app via Bluetooth and securely stored in the cloud for further analysis. The technology aims to provide healthcare professionals with deeper insights into patient conditions, enhancing treatment plans and contributing to research.

Founded with the mission of improving lung health, Strados Labs operates offices in Philadelphia and Atlanta. The company emphasizes an objective approach to capturing patient data, which has been validated through extensive use across multiple continents and languages. Their focus extends beyond simple cough detection to encompass a more comprehensive understanding of respiratory issues, benefiting various therapeutic areas including asthma, chronic cough, COPD, and idiopathic pulmonary fibrosis (IPF).